FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040241387> ?p ?o ?g. }

• W2040241387 endingPage "251" @default.
• W2040241387 startingPage "251" @default.
• W2040241387 abstract "A randomized controlled trial of preprocedure administration of parecoxib for therapeutic endoscopic retrograde cholangiopancreatography Somchai Amornyotin, Wiyada Chalayonnawin, Siriporn KongphlayDepartment of Anesthesiology and Siriraj GI Endoscopy Center, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, ThailandIntroduction: Parecoxib is occasionally used for analgesia in postprocedural patients. The clinical efficacy of parecoxib used for endoscopic retrograde cholangiopancreatography (ERCP) is controversial. The aim of the study was to determine the clinical efficacy of preprocedure administration of parecoxib for therapeutic ERCP patients.Methods: Eighty-five patients who underwent therapeutic ERCP in a single year were randomly assigned to normal saline group (C, n = 43) and parecoxib group (P, n = 42). Patients in group C received normal saline and those in group P received 40 mg of parecoxib intravenously in equivalent volume. Patients in both groups received the saline or parecoxib 60 seconds before administration of the sedative agents. All patients were monitored for the depth of sedation by using the NarcotrendTM monitor, maintaining stage D0–E0 during ERCP. All patients were oxygenated with 100% O2 via nasal cannula and sedated with 0.03 mg/kg of intravenous midazolam and 1 µg/kg of intravenous fentanyl as well as the titration of intravenous propofol. After the ERCP procedure, pethidine in an intramuscular dose of 0.5–1.0 mg/kg was used as rescue medication. The pain scores (visual analog scale [VAS], 0–10) at 2, 12, and 24 hours post-ERCP, the total number of doses of pethidine used, the dose volume of pethidine used, patient satisfaction, endoscopist satisfaction, and complications were recorded.Results: There were no significant differences in sedative and analgesic agents used during the procedure, pain at 24 hours post-ERCP, endoscopist satisfaction, and complications in both groups. The total number of doses of pethidine used post-ERCP in group C was significantly higher than in group P. Additionally, the mean pain score at 2 and 12 hours post-ERCP in group C was significantly greater than in group P. Patient satisfaction in group P was higher than in group C.Conclusion: Preprocedure administration of parecoxib for therapeutic ERCP patients was clinically effective. The analgesic efficacy of a standard dose of parecoxib was clearly demonstrated during the first 12 hours postprocedure. Additionally, patient satisfaction in the parecoxib group was also higher than in the control group.Keywords: parecoxib, endoscopic retrograde cholangiopancreatography, clinical efficacy, preprocedure" @default.
• W2040241387 created "2016-06-24" @default.
• W2040241387 creator A5044101652 @default.
• W2040241387 creator A5070160076 @default.
• W2040241387 creator A5072013182 @default.
• W2040241387 date "2012-08-01" @default.
• W2040241387 modified "2023-09-29" @default.
• W2040241387 title "A randomized controlled trial of preprocedure administration of parecoxib for therapeutic endoscopic retrograde cholangiopancreatography" @default.
• W2040241387 cites W1984082177 @default.
• W2040241387 cites W1999315296 @default.
• W2040241387 cites W2000988011 @default.
• W2040241387 cites W2001589248 @default.
• W2040241387 cites W2019106207 @default.
• W2040241387 cites W2023021065 @default.
• W2040241387 cites W2026743852 @default.
• W2040241387 cites W2057803981 @default.
• W2040241387 cites W2058691836 @default.
• W2040241387 cites W2059701823 @default.
• W2040241387 cites W2074631919 @default.
• W2040241387 cites W2075560619 @default.
• W2040241387 cites W2080745496 @default.
• W2040241387 cites W2091696702 @default.
• W2040241387 cites W2103685579 @default.
• W2040241387 cites W2108589720 @default.
• W2040241387 cites W2112316832 @default.
• W2040241387 cites W2121761530 @default.
• W2040241387 cites W2129568786 @default.
• W2040241387 cites W2142699862 @default.
• W2040241387 cites W2150998739 @default.
• W2040241387 cites W82338767 @default.
• W2040241387 doi "https://doi.org/10.2147/jpr.s33546" @default.
• W2040241387 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3442739" @default.
• W2040241387 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23049274" @default.
• W2040241387 hasPublicationYear "2012" @default.
• W2040241387 type Work @default.
• W2040241387 sameAs 2040241387 @default.
• W2040241387 citedByCount "6" @default.
• W2040241387 countsByYear W20402413872013 @default.
• W2040241387 countsByYear W20402413872014 @default.
• W2040241387 countsByYear W20402413872017 @default.
• W2040241387 crossrefType "journal-article" @default.
• W2040241387 hasAuthorship W2040241387A5044101652 @default.
• W2040241387 hasAuthorship W2040241387A5070160076 @default.
• W2040241387 hasAuthorship W2040241387A5072013182 @default.
• W2040241387 hasBestOaLocation W20402413871 @default.
• W2040241387 hasConcept C141071460 @default.
• W2040241387 hasConcept C14184104 @default.
• W2040241387 hasConcept C168563851 @default.
• W2040241387 hasConcept C2775967933 @default.
• W2040241387 hasConcept C2776814716 @default.
• W2040241387 hasConcept C2777397205 @default.
• W2040241387 hasConcept C2778000748 @default.
• W2040241387 hasConcept C2778444009 @default.
• W2040241387 hasConcept C2779262571 @default.
• W2040241387 hasConcept C2780820201 @default.
• W2040241387 hasConcept C2781072394 @default.
• W2040241387 hasConcept C2781168792 @default.
• W2040241387 hasConcept C42219234 @default.
• W2040241387 hasConcept C71924100 @default.
• W2040241387 hasConceptScore W2040241387C141071460 @default.
• W2040241387 hasConceptScore W2040241387C14184104 @default.
• W2040241387 hasConceptScore W2040241387C168563851 @default.
• W2040241387 hasConceptScore W2040241387C2775967933 @default.
• W2040241387 hasConceptScore W2040241387C2776814716 @default.
• W2040241387 hasConceptScore W2040241387C2777397205 @default.
• W2040241387 hasConceptScore W2040241387C2778000748 @default.
• W2040241387 hasConceptScore W2040241387C2778444009 @default.
• W2040241387 hasConceptScore W2040241387C2779262571 @default.
• W2040241387 hasConceptScore W2040241387C2780820201 @default.
• W2040241387 hasConceptScore W2040241387C2781072394 @default.
• W2040241387 hasConceptScore W2040241387C2781168792 @default.
• W2040241387 hasConceptScore W2040241387C42219234 @default.
• W2040241387 hasConceptScore W2040241387C71924100 @default.
• W2040241387 hasLocation W20402413871 @default.
• W2040241387 hasLocation W20402413872 @default.
• W2040241387 hasLocation W20402413873 @default.
• W2040241387 hasLocation W20402413874 @default.
• W2040241387 hasOpenAccess W2040241387 @default.
• W2040241387 hasPrimaryLocation W20402413871 @default.
• W2040241387 hasRelatedWork W1606515202 @default.
• W2040241387 hasRelatedWork W2009987026 @default.
• W2040241387 hasRelatedWork W2090840481 @default.
• W2040241387 hasRelatedWork W2361468386 @default.
• W2040241387 hasRelatedWork W2389004264 @default.
• W2040241387 hasRelatedWork W2409581964 @default.
• W2040241387 hasRelatedWork W2796462601 @default.
• W2040241387 hasRelatedWork W2887406189 @default.
• W2040241387 hasRelatedWork W4200501500 @default.
• W2040241387 hasRelatedWork W3032195257 @default.
• W2040241387 isParatext "false" @default.
• W2040241387 isRetracted "false" @default.
• W2040241387 magId "2040241387" @default.
• W2040241387 workType "article" @default.